HNOI — HNO International Income Statement
0.000.00%
- $12.96m
- $14.39m
- $0.07m
Annual income statement for HNO International, fiscal year end - October 31st, USD millions except per share, conversion factor applied.
2021 October 31st | 2022 October 31st | R2023 October 31st | R2024 October 31st | 2025 October 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0.034 | 0.013 | 0.004 | 0.066 |
| Cost of Revenue | |||||
| Gross Profit | 0 | 0.007 | 0.007 | 0.001 | 0.066 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.133 | 1.11 | 1.92 | 3.32 | 6.63 |
| Operating Profit | -0.133 | -1.07 | -1.9 | -3.32 | -6.57 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.133 | -1.07 | -1.93 | -3.34 | -6.62 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.133 | -1.07 | -1.93 | -3.34 | -6.62 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.133 | -1.07 | -1.93 | -3.34 | -6.62 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.133 | -1.07 | -1.93 | -3.34 | -6.62 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.001 | -0.011 | -0.005 | -0.008 | -0.043 |